Omicsgen Lifesciences Private Limited, a active private limited company, was established on 29 August 2017 in Kanayannur, Kerala, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999KL2017PTC050248. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.90 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Its leadership includes Puthuvayankunnath Sankaraprabha Beena (Director), Aardhra Santhosh (Director), Santhosh Aravind Vilas (Director). Past directors included Santha Krishnankutty, Chithra Nair Ramachandran. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.32E, Block No.6, Kinfra Hitech Park, Kanayannur, Kerala, 683503.
U74999KL2017PTC050248
050248
29 August 2017
₹0.90 M
₹0.90 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Omicsgen Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Puthuvayankunnath Sankaraprabha Beena | Director | 29 Aug 2017 | Current |
| Aardhra Santhosh | Director | 15 Jan 2020 | Current |
| Santhosh Aravind Vilas | Director | 16 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2017 | Past |
| Pramod Abcsdd | Director | 17 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omicsgen Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 67.62% increase. The company also saw a substantial improvement in profitability, with a 419.58% increase in profit. The company's net worth Soared by an impressive increase of 753.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Omicsgen Lifesciences had a promoter holding of 81.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Omicsgen Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Omicsgen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omicsgen Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Omicsgen Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Omicsgen Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity Aardhra Santhosh was appointed as a Director was appointed as a Director on 15 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The activity Santhosh Aravind Vilas was appointed as a Director was appointed as a Director on 16 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
Puthuvayankunnath Sankaraprabha Beena was appointed as a Director was appointed as a Director on 29 Aug 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
The activity Omicsgen Lifesciences Private Limited was registered on 29 Aug 2017 with Roc Ernakulam & aged 8 years 3 months as per MCA records. was completed.
The CIN of Omicsgen Lifesciences Private Limited is U74999KL2017PTC050248.
Omicsgen Lifesciences Private Limited is headquartered at Plot No.32E, Block No.6, Kinfra Hitech Park, Kanayannur, Kerala, 683503.
Omicsgen Lifesciences Private Limited was incorporated on 29 August 2017.
The current directors of Omicsgen Lifesciences Private Limited are
The primary industry of Omicsgen Lifesciences Private Limited is Professional, Scientific And Technical.
Omicsgen Lifesciences Private Limited is unlisted.
The authorized capital of Omicsgen Lifesciences Private Limited is ₹0.90 M, and the paid-up capital is ₹0.90 M.
The compliance status of Omicsgen Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX